home All News open_in_new Full Article

BioNTech kupuje CureVac: Nemecký gigant posilňuje výskum liekov proti rakovine za miliardu eur

Nemecká farmaceutická spoločnosť BioNTech prevezme svojho konkurenta CureVac. Zúčastnené strany podpísali záväznú kúpnu zmluvu, ktorá oceňuje spoločnosť CureVac na 1,25 miliardy amerických dolárov (1,09 miliardy eur), oznámila vo štvrtok spoločnosť


today 7 d. ago attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other


ID: 2842149786
Add Watch Country

arrow_drop_down